Analystreport

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its price target lowered by analysts at Roth Capital from $3.00 to $1.22. They now have a "neutral" rating on the stock.

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com